These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17327908)

  • 61. Chemosensitivity testing of small cell lung cancer using the MTT assay.
    Campling BG; Pym J; Baker HM; Cole SP; Lam YM
    Br J Cancer; 1991 Jan; 63(1):75-83. PubMed ID: 1846554
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells.
    Sadava D; Phillips T; Lin C; Kane SE
    Cancer Lett; 2002 May; 179(2):151-6. PubMed ID: 11888669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biological heterogeneity of small cell lung cancer.
    Carney DN; Gazdar AF; Nau M; Minna JD
    Semin Oncol; 1985 Sep; 12(3):289-303. PubMed ID: 2996148
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of epigenetics in cancer initiation and progression.
    Chik F; Szyf M; Rabbani SA
    Adv Exp Med Biol; 2011; 720():91-104. PubMed ID: 21901621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain.
    Xu ZH; Miao ZW; Jiang QZ; Gan DX; Wei XG; Xue XZ; Li JQ; Zheng F; Qin XX; Fang WG; Chen YH; Li B
    FASEB J; 2019 Feb; 33(2):1742-1757. PubMed ID: 30183374
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression.
    Chen H; Hao J; Wang L; Li Y
    Br J Cancer; 2009 Aug; 101(3):432-40. PubMed ID: 19603017
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of extracellular matrix in small-cell lung cancer.
    Rintoul RC; Sethi T
    Lancet Oncol; 2001 Jul; 2(7):437-42. PubMed ID: 11905738
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell lines.
    Thomson JA; Leonard JH; McGregor K; Sturm RA; Parsons PG
    Int J Cancer; 1994 Jul; 58(2):285-90. PubMed ID: 8026890
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapy-induced enrichment of putative lung cancer stem-like cells.
    Freitas DP; Teixeira CA; Santos-Silva F; Vasconcelos MH; Almeida GM
    Int J Cancer; 2014 Mar; 134(6):1270-8. PubMed ID: 24105655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bone Marrow Urokinase Plasminogen Activator Receptor Levels are Associated with the Progress of Multiple Myeloma.
    Shou LH; Cao D; Dong XH; Fang Q; Xu BL; Fei JP
    Chin Med Sci J; 2016 Sep; 31(3):155-160. PubMed ID: 27733222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Smoking, inflammation and small cell lung cancer: recent developments.
    Hamilton G; Rath B
    Wien Med Wochenschr; 2015 Oct; 165(19-20):379-86. PubMed ID: 26289596
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines.
    Hofmann J; Kaiser U; Maasberg M; Havemann K
    Eur J Cancer; 1995 Nov; 31A(12):2053-8. PubMed ID: 8562165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effects of apigenin on self-renewal and 
uPAR expression in NCI-H446 cell line].
    Shu L; Yuan Q; Cui Y; Sun S; Chen A; Chen D; Cao J; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1124-1127. PubMed ID: 27932755
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative proteomics of small cell lung carcinoma.
    Ziv T; Barnea E; Segal H; Sharon R; Beer I; Admon A
    Cancer Biomark; 2006; 2(6):219-34. PubMed ID: 17264394
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human small cell lung cancer cells produce brain natriuretic peptide.
    Ohsaki Y; Gross AJ; Le PT; Oie H; Johnson BE
    Oncology; 1999; 56(2):155-9. PubMed ID: 9949302
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.
    Smit EF; de Vries EG; Timmer-Bosscha H; de Leij LF; Oosterhuis JW; Scheper RJ; Weening JJ; Postmus PE; Mulder NH
    Int J Cancer; 1992 Apr; 51(1):72-8. PubMed ID: 1314232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer.
    Morgan SA; Watson JV; Twentyman PR; Smith PJ
    Br J Cancer; 1989 Sep; 60(3):282-7. PubMed ID: 2477051
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro chemical eradication of small cell lung cancer: application in autologous bone marrow transplantation.
    Benard J; Bettan-Renaud L; Gavoille A; Pico JL; Beaujean F; Lopez M; Riou G
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1561-6. PubMed ID: 2850190
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-nonspecific agents under the clinically equivalent area under the curve.
    Mitsuhashi Y; Inaba M; Sugiyama Y; Kobayashi T
    Cancer; 1992 Nov; 70(10):2540-6. PubMed ID: 1330284
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of conditioned medium proteins from human cancer cells adapted to serum-free conditions.
    Doyle LA; Goldstein LH; Clingroth CJ; Cuttitta F
    Anal Biochem; 1990 Nov; 190(2):238-43. PubMed ID: 1705394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.